最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/10/6。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 414
- 預計賣出市值
- $14.1 億
- 賣方
- 117
- 公司
- 37
- 依 10b5-1 計畫
- 221
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| VIRVir Biotechnology, Inc. | 2026/2/2416:33 ET | Vicki Lee Sato董事 | 2.04 萬 | $15.1 萬 | 2026/2/2410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| FTHFaeth Therapeutics, Inc. | 2026/2/2416:11 ET | Celebi John前高階主管 | 3,374 | $11.6 萬 | 2026/2/24 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/2/2316:52 ET | O'Byrne Jason高階主管 | 2,089 | $1.56 萬 | 2026/2/23 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/2/2316:34 ET | Eisner Mark高階主管 | 2,089 | $1.56 萬 | 2026/2/23 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/2/2316:32 ET | De Backer Marianne高階主管 · 董事 | 1.90 萬 | $14.2 萬 | 2026/2/23 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/2/2316:22 ET | de Verneuil Vanina高階主管 | 4,445 | $3.31 萬 | 2026/2/23 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/2/2316:18 ET | Sabatini Brent高階主管 | 1,829 | $1.36 萬 | 2026/2/23 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | 2026/2/1912:09 ET | Rossi Dino A董事 | 1.90 萬 | $495.4 萬 | 2026/2/19 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1911:03 ET | Menon Rajeev高階主管 | 3,492 | $123.6 萬 | 2026/2/19 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/2/1909:56 ET | Boulding Mark Elliott高階主管 | 3,019 | $20.7 萬 | 2026/2/1910b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/2/1816:38 ET | Boulding Mark Elliott高階主管 | 3,081 | $21.4 萬 | 2026/2/18 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1814:22 ET | Breland Benjamin T.高階主管 | 2,000 | $71.6 萬 | 2026/2/18 | Fidelity Brokerage Services LLC | SEC |
| FTHFaeth Therapeutics, Inc. | 2026/2/1813:22 ET | Peyer JamesFomer Director | 950 | $2.58 萬 | 2026/2/18 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1813:19 ET | Brown William P高階主管 | 9,456 | $338.8 萬 | 2026/2/18 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1812:30 ET | Oberg Kathleen K.高階主管 | 1.28 萬 | $454.7 萬 | 2026/2/18 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1811:28 ET | Menon Rajeev高階主管 | 6,333 | $225.8 萬 | 2026/2/18 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1715:29 ET | Capuano Anthony高階主管 · 董事 | 6.30 萬 | $2,236 萬 | 2026/2/17 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1715:08 ET | Pinto Drew高階主管 | 4,000 | $143.9 萬 | 2026/2/17 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/2/1712:51 ET | Boulding Mark Elliott高階主管 | 2,813 | $19.4 萬 | 2026/2/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1710:52 ET | Marriott David SChairman of The Board | 4,747 | $160.0 萬 | 2026/2/17 | Raymond James & Associates, Inc. | SEC |
| MARMarriott International Inc | 2026/2/1316:24 ET | Oberg Kathleen K.高階主管 | 4,880 | $174.3 萬 | 2026/2/13 | Fidelity Brokerage Services LLC | SEC |
| MARMarriott International Inc | 2026/2/1315:49 ET | Reiss Rena Hozore高階主管 | 2,512 | $89.7 萬 | 2026/2/13 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/2/1315:46 ET | Sabatini Brent高階主管 | 1,530 | $1.19 萬 | 2026/2/13 | Fidelity Brokerage Services LLC | SEC |
| CLColgate Palmolive Co | 2026/2/1216:30 ET | Tsourapas Panagiotis高階主管 | 1.50 萬 | $146.7 萬 | 2026/2/12 | Merrill Lynch | SEC |
| CLColgate Palmolive Co | 2026/2/1116:05 ET | Tsourapas Panagiotis高階主管 | 3.50 萬 | $331.1 萬 | 2026/2/11 | Merrill Lynch | SEC |
| KRYSKrystal Biotech, Inc. | 2026/2/916:04 ET | Romano Kathryn高階主管 | 1.25 萬 | $345.8 萬 | 2026/2/910b5-1 | Fidelity Brokerage Services LLC | SEC |
| LBRTLiberty Energy Inc. | 2026/2/616:02 ET | Elliott R Sean高階主管 | 2.50 萬 | $63.5 萬 | 2026/2/6 | Charles Schwab & Co., Inc. | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/416:52 ET | Patrick Burnett高階主管 | 9,794 | $25.3 萬 | 2026/2/410b5-1 | Merrill Lynch | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/2/317:09 ET | Harlan Robins高階主管 | 8,120 | $15.0 萬 | 2026/2/310b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/218:19 ET | Masaru Matsuda高階主管 | 4.06 萬 | $102.7 萬 | 2026/2/210b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/218:17 ET | Todd Edwards高階主管 | 2,052 | $5.23 萬 | 2026/2/2 | Merrill | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/218:15 ET | Latha Vairavan高階主管 | 1,320 | $3.37 萬 | 2026/2/2 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/217:48 ET | Patrick Burnett高階主管 | 3,675 | $9.37 萬 | 2026/2/2 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/217:41 ET | Todd Frank Watanabe高階主管 | 1.98 萬 | $50.6 萬 | 2026/2/2 | Merrill | SEC |
| AXSMAxsome Therapeutics, Inc. | 2026/2/217:30 ET | Herriot Tabuteau高階主管 | 3.24 萬 | $602.4 萬 | 2026/2/210b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/2/217:26 ET | Harlan Robins高階主管 | 3.47 萬 | $63.8 萬 | 2026/2/210b5-1 | Goldman Sachs & Co. LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/2/217:24 ET | Chad Robins高階主管 | 12.5 萬 | $229.9 萬 | 2026/2/210b5-1 | Goldman Sachs & Co. LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/2/217:04 ET | Howard Welgus董事 | 1.00 萬 | $25.0 萬 | 2026/2/210b5-1 | Merrill | SEC |
| FTHFaeth Therapeutics, Inc. | 2026/1/2717:33 ET | Ringo William R前董事 | 1,169 | $1.15 萬 | 2026/1/27 | Fidelity Brokerage Services LLC | SEC |
| MPMP Materials Corp. | 2026/1/2016:36 ET | Elliot Hoops高階主管 | 7,823 | $53.4 萬 | 2026/1/2010b5-1 | Merrill | SEC |
| IOTSamsara Inc. | 2026/1/1516:04 ET | Kirchhoff Benjamin Louis高階主管 | 3,414 | $11.8 萬 | 2026/1/1510b5-1 | Charles Schwab & Co., Inc. | SEC |
| VIRVir Biotechnology, Inc. | 2026/1/1421:00 ET | SVF Endurance (Cayman) Limited股東 | 125.1 萬 | $853.4 萬 | 2026/1/1410b5-1 | BTIG, LLC | SEC |
| ATRAAtara Biotherapeutics, Inc. | 2026/1/1221:26 ET | Panacea Innovation Ltd持股 10% 以上股東 | 8.06 萬 | $47.4 萬 | 2026/1/12 | Cantor Fitzgerald | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/1/1216:27 ET | Francis Lo高階主管 | 6.43 萬 | $101.3 萬 | 2026/1/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/1/1216:26 ET | Kyle Piskel高階主管 | 1.11 萬 | $17.5 萬 | 2026/1/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/1/916:11 ET | Boulding Mark Elliott高階主管 | 2,314 | $18.0 萬 | 2026/1/910b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/1/816:17 ET | Boulding Mark Elliott高階主管 | 1,286 | $9.83 萬 | 2026/1/8 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/1/816:10 ET | Boulding Mark Elliott高階主管 | 2,747 | $21.0 萬 | 2026/1/810b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | 2026/1/716:44 ET | Herriot Tabuteau高階主管 | 3.13 萬 | $533.6 萬 | 2026/1/710b5-1 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/1/716:37 ET | Boulding Mark Elliott高階主管 | 3,376 | $26.1 萬 | 2026/1/710b5-1 | Fidelity Brokerage Services LLC | SEC |